Endo to buy Penwest for Opana ER tech
Endo Pharmaceuticals will pay $168m (€127.7m) for drug delivery tech and formulations firm Penwest Pharmaceuticals in bid to expand pain portfolio.
Archives for August 9, 2010
Parexel grows revenue, op income in Q4 & full fiscal year
Parexel recorded growth in the fourth quarter, contributing to a 10 per cent increase in full year GAAP operating income and an improved backlog.
Appointments at Kendle, Invida and Global Research Services (GRS) – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Kendle, Invida and Global Research Services (GRS).
License adds anti-counterfeiting tech to ATL pharma labels
Label manufacturer ATL has licensed anti-counterfeiting technologies from Document Security Systems (DSS) to meet growing demand from pharma clients.
Synthetech says revs down in Q1; unveils plans to expand
Lower overseas demand from key customers hurt fine chemicals maker Synthetech in first quarter fiscal 2011, continuing the decline seen in the previous financial year